Comparative Pharmacology
Head-to-head clinical analysis: DECA DURABOLIN versus MAXIBOLIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DECA DURABOLIN versus MAXIBOLIN.
DECA-DURABOLIN vs MAXIBOLIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Nandrolone decanoate is an anabolic steroid that binds to androgen receptors, increasing protein synthesis and promoting muscle growth. It also stimulates erythropoietin production, increasing red blood cell mass.
MAXIBOLIN (methandienone) is an anabolic steroid that binds to androgen receptors, increasing protein synthesis and nitrogen retention in muscle tissue. It also inhibits glucocorticoid receptors, reducing catabolism and promoting anabolic effects.
Intramuscular injection of 100-200 mg every 1-3 weeks for anabolic effects; for replacement therapy, 50-100 mg every 2-4 weeks.
Oral: 2 mg three times daily; optimal response may require 4-8 mg daily for 2-3 weeks, then reduce to maintenance of 2-4 mg daily.
None Documented
None Documented
Terminal half-life of nandrolone decanoate is 4.3 hours for the decanoate ester, but the active metabolite nandrolone has a prolonged half-life of 6-7 days due to slow release from intramuscular depot and enterohepatic recirculation; clinical effects persist for 3-4 weeks.
Terminal elimination half-life of 9-10 hours; supports every-other-day dosing in androgen replacement therapy.
Primarily renal (90% as metabolites, 5% unchanged); fecal elimination accounts for <5%.
Primarily renal (90% as metabolites, 5% unchanged); biliary/fecal elimination accounts for approximately 10%.
Category C
Category C
Anabolic Steroid
Anabolic Steroid